Omkar Pharmachem Ltd
Incorporated in 1995, Omkar Pharmachem Ltd manufactures chemicals used in pharmaceuticals.
- Market Cap ₹ 22.6 Cr.
- Current Price ₹ 22.4
- High / Low ₹ 26.2 / 18.4
- Stock P/E 113
- Book Value ₹ 9.10
- Dividend Yield 0.00 %
- ROCE 3.29 %
- ROE 2.24 %
- Face Value ₹ 10.0
Pros
- Company has reduced debt.
- Company is almost debt free.
Cons
- Promoter holding is low: 0.03%
- Company has a low return on equity of 2.29% over last 3 years.
- Debtor days have increased from 60.8 to 87.9 days.
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Peer comparison
Sector: Miscellaneous Industry: Miscellaneous
Quarterly Results
Figures in Rs. Crores
Profit & Loss
Figures in Rs. Crores
Mar 2012 | Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | TTM | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
0.07 | 0.06 | 0.07 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.05 | 0.27 | 0.54 | 0.54 | 0.56 | |
0.07 | 0.07 | 0.07 | 0.06 | 0.12 | 0.22 | 0.24 | 0.38 | 0.26 | 0.24 | 0.27 | 0.22 | 0.24 | |
Operating Profit | 0.00 | -0.01 | 0.00 | -0.06 | -0.12 | -0.22 | -0.24 | -0.38 | -0.21 | 0.03 | 0.27 | 0.32 | 0.32 |
OPM % | 0.00% | -16.67% | 0.00% | -420.00% | 11.11% | 50.00% | 59.26% | 57.14% | |||||
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.49 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
Interest | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.01 | 0.04 | 0.05 | 0.06 | 0.06 | 0.05 | 0.05 |
Depreciation | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Profit before tax | 0.00 | -0.01 | 0.00 | -0.06 | -0.12 | 0.27 | -0.25 | -0.42 | -0.26 | -0.03 | 0.21 | 0.27 | 0.27 |
Tax % | 0.00% | 0.00% | 0.00% | 18.52% | 0.00% | 0.00% | 0.00% | 866.67% | 14.29% | 25.93% | |||
0.00 | -0.01 | 0.00 | -0.06 | -0.12 | 0.22 | -0.26 | -0.42 | -0.26 | 0.22 | 0.18 | 0.20 | 0.20 | |
EPS in Rs | 0.00 | -0.01 | 0.00 | -0.06 | -0.12 | 0.22 | -0.26 | -0.42 | -0.26 | 0.22 | 0.18 | 0.20 | 0.20 |
Dividend Payout % | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Compounded Sales Growth | |
---|---|
10 Years: | 25% |
5 Years: | % |
3 Years: | 121% |
TTM: | 0% |
Compounded Profit Growth | |
---|---|
10 Years: | 36% |
5 Years: | 23% |
3 Years: | 40% |
TTM: | -5% |
Stock Price CAGR | |
---|---|
10 Years: | % |
5 Years: | 11% |
3 Years: | 3% |
1 Year: | -10% |
Return on Equity | |
---|---|
10 Years: | -1% |
5 Years: | 0% |
3 Years: | 2% |
Last Year: | 2% |
Balance Sheet
Figures in Rs. Crores
Mar 2012 | Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Sep 2023 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Equity Capital | 10.08 | 10.08 | 10.08 | 10.08 | 10.08 | 10.08 | 10.08 | 10.08 | 10.08 | 10.08 | 10.08 | 10.08 | 10.08 |
Reserves | -0.74 | -0.75 | -0.75 | -0.81 | -0.93 | -0.71 | -0.96 | -1.38 | -1.64 | -1.42 | -1.24 | -1.04 | -0.90 |
0.01 | 0.01 | 0.01 | 0.01 | 0.00 | 0.00 | 0.24 | 0.58 | 0.87 | 0.90 | 0.93 | 0.62 | 0.49 | |
0.12 | 0.12 | 0.11 | 0.13 | 0.57 | 0.06 | 0.04 | 0.05 | 0.06 | 0.08 | 0.06 | 0.07 | 0.04 | |
Total Liabilities | 9.47 | 9.46 | 9.45 | 9.41 | 9.72 | 9.43 | 9.40 | 9.33 | 9.37 | 9.64 | 9.83 | 9.73 | 9.71 |
0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.00 | 0.01 | 0.00 | 0.00 | 0.00 | 0.01 | 0.00 | 0.01 | |
CWIP | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Investments | 9.30 | 9.30 | 9.30 | 9.30 | 9.30 | 9.30 | 9.30 | 9.30 | 9.30 | 9.30 | 9.30 | 9.30 | 9.30 |
0.16 | 0.15 | 0.14 | 0.10 | 0.41 | 0.13 | 0.09 | 0.03 | 0.07 | 0.34 | 0.52 | 0.43 | 0.40 | |
Total Assets | 9.47 | 9.46 | 9.45 | 9.41 | 9.72 | 9.43 | 9.40 | 9.33 | 9.37 | 9.64 | 9.83 | 9.73 | 9.71 |
Cash Flows
Figures in Rs. Crores
Mar 2012 | Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
-0.04 | -0.03 | 0.01 | -0.05 | 0.34 | -0.77 | -0.25 | -0.30 | -0.21 | 0.02 | 0.20 | 0.28 | |
0.08 | 0.00 | 0.00 | 0.00 | 0.00 | 0.49 | -0.01 | 0.00 | 0.00 | 0.00 | -0.01 | 0.00 | |
0.00 | 0.00 | 0.00 | 0.00 | -0.01 | 0.01 | 0.23 | 0.30 | 0.24 | -0.02 | -0.03 | -0.35 | |
Net Cash Flow | 0.04 | -0.03 | 0.01 | -0.05 | 0.33 | -0.28 | -0.03 | 0.00 | 0.02 | 0.00 | 0.17 | -0.08 |
Ratios
Figures in Rs. Crores
Mar 2012 | Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Debtor Days | 365.00 | 608.33 | 365.00 | 146.00 | 40.56 | 54.07 | 87.87 | |||||
Inventory Days | ||||||||||||
Days Payable | ||||||||||||
Cash Conversion Cycle | 365.00 | 608.33 | 365.00 | 146.00 | 40.56 | 54.07 | 87.87 | |||||
Working Capital Days | -156.43 | 0.00 | -52.14 | -219.00 | -54.07 | 20.28 | 40.56 | |||||
ROCE % | 0.00% | -0.11% | 0.00% | -0.64% | -1.30% | -2.27% | -2.56% | -4.08% | -2.26% | 0.32% | 2.79% | 3.29% |
Documents
Announcements
- Compliances- Submission Of Certificate Under Regulation 40 (9) Of SEBI (LODR) Regulations, 2015 2d
-
Compliances-Compliance Certificate For The March, 31 2024
18 Apr - Compliance Certificate under regulation 7(3) of SEBI LODR (Listing Obligation and Disclosure requirements) Regulations, 2015 for the year ended 31st March 2024
-
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
12 Apr - Certificate under regulation 74(5) of the SEBI (Depositories and participants) Regulations, 2018 for the quarter ended on March 31, 2024
- Closure of Trading Window 27 Mar
-
Announcement under Regulation 30 (LODR)-Newspaper Publication
15 Feb - Dear Sir, Please find News papers publication of Quarter and Nine months ended as on 31st December 2023
Annual reports
-
Financial Year 2023
from bse
-
Financial Year 2022
from bse
-
Financial Year 2021
from bse
-
Financial Year 2020
from bse
-
Financial Year 2019
from bse
-
Financial Year 2018
from bse
-
Financial Year 2017
from bse
-
Financial Year 2016
from bse
-
Financial Year 2015
from bse
-
Financial Year 2014
from bse
-
Financial Year 2013
from bse
-
Financial Year 2012
from bse
-
Financial Year 2011
from bse
-
Financial Year 2010
from bse
-
Financial Year 2009
from bse
Product Profile:[1][2]
a) Sodium bi-sulphite
b) Sodium meta bi-sulphite
c) Sodium sulphite
d) Sulphur
e) Specialty chemicals
f) Ciba specialty chemicals
g) Organic chemicals